Researchers track Long-Term effects of schizophrenia medication
NCT ID NCT01626872
Summary
This study aimed to check the long-term safety and effectiveness of an investigational medication called MP-214 for people with schizophrenia. It included 254 patients who had already finished a related earlier study. The main goal was to monitor for any side effects and see how well the drug worked over an extended period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Sapporo, Hokkaido, Japan
-
Study site
Seoul, South Korea
-
Study site
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.